Macular degeneration: open trials in Czechia

13 open trials have a site in Czechia. Registry data; only the trial team decides who can take part.

NCT06847542
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Trial Treatment · Phase 3 · Hoffmann-La Roche
Oblastni nemocnice Mlada Boleslav, a.s., nemocnice Stredoceskeho kraje, Mladá Boleslav · Fakultni nemocnice Ostrava, Ostrava · Fakultni nemocnice Kralovske Vinohrady, Prague · Ustredni Vojenska Nemocnice Vojenska Fakultni Nemocnice Praha, Prague 6
Registry updated 2026-11-06
NCT06635148
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC
Fakultni nemocnice Kralovske Vinohrady, Prague · Axon Clinical s.r.o., Prague 5
Registry updated 2026-11-03
NCT07007065
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Trial Treatment · Phase 3 · AbbVie
Fakultni nemocnice Ostrava, Ostrava · Fakultni nemocnice Kralovske Vinohrady, Prague · Vseobecna fakultni nemocnice v Praze, Prague · Ustredni Vojenska Nemocnice Vojenska Fakultni Nemocnice Praha, Prague 6
Registry updated 2026-10-29
NCT07614776
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Trial Treatment · Phase 3 · Amgen
Oblastni nemocnice Mlada Boleslav, a.s., nemocnice Stredoceskeho kraje, Mladá Boleslav · VISUS, spol s.r.o., Náchod · Fakultni nemocnice Ostrava, Ostrava · Oftex s.r.o., Pardubice V · Fakultni Nemocnice Plzen, Plzen 23 · Fakultni nemocnice Kralovske Vinohrady, Prague · Vseobecna fakultni nemocnice v Praze, Prague · Axon Clinical s.r.o., Prague 5
Registry updated 2026-10-14
NCT07441642
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Prague
Registry updated 2026-10-13
2026-526648-11-00
A Phase II/III Multicenter, Randomized, Masked, Active Comparator-Controlled Study to Evaluate the Safety and Efficacy of Two Doses of OCUL101, an Anti-VEGF and Anti-Complement C5, Bi-specific Humanized Antibody-Like “trap” in Participants with Neovascular Age-Related Macular Degeneration with or without Geographic Atrophy – STAT Study
Trial Treatment · Phase 2/3 · Shenzhen Oculgen Biomedical Technology Co. Ltd.
Fakultni nemocnice Ostrava, Ostrava · Oftex s.r.o., Pardubice V · Vseobecna fakultni nemocnice v Praze, Prague · Fakultni nemocnice Kralovske Vinohrady, Prague · Axon Clinical s.r.o., Prague 5
Registry updated 2026-09-25
NCT07606365
A Study in Adults With Geographic Atrophy
Trial Treatment · Phase 2 · Sitala Bio LTD
Oftex s.r.o., Pardubice V · Fakultni nemocnice Kralovske Vinohrady, Prague · Axon Clinical s.r.o., Prague 5
Registry updated 2026-09-21
2025-524894-17-00
A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)
Trial Treatment · Phase 2/3 · Eyebiotech Limited
Oblastni nemocnice Mlada Boleslav, a.s., nemocnice Stredoceskeho kraje, Mladá Boleslav · VISUS, spol s.r.o., Náchod · Fakultni nemocnice Ostrava, Ostrava · Astra Clinic.s.r.o., Prague · Fakultni nemocnice Kralovske Vinohrady, Prague · Axon Clinical s.r.o., Prague 5
Registry updated 2026-09-10
NCT06659445
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Trial Treatment · Phase 2 · ONL Therapeutics
VISUS, spol s.r.o., Náchod · Vseobecna fakultni nemocnice v Praze, Prague · Fakultni nemocnice Kralovske Vinohrady, Prague · Axon Clinical s.r.o., Prague 5 · Medical Private Care s.r.o., Sokolov
Registry updated 2026-09-10
NCT06990269
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Trial Treatment · Phase 2 · ADARx Pharmaceuticals, Inc.
Prague · Praha Klanovice
Registry updated 2026-09-03
NCT07496567
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Trial Treatment · Phase 2/3 · EyeBiotech Ltd.
Klaudians Hospital - Ophthalmology department, Mladá Boleslav · VISUS, spol s.r.o., Náchod · Astra Clinic.s.r.o., Prague · Axon Clinical, s.r.o. (Site 400), Prague · Fakultni nemocnice Kralovske, Prague
Registry updated 2026-08-06
2025-523704-77-00
A clinical trial to learn more about the effects of FWY003 in people with geographic atrophy associated with age-related macular degeneration.
Trial Treatment · Phase 2 · Novartis Pharma AG
Vseobecna fakultni nemocnice v Praze, Prague · Fakultni nemocnice Kralovske Vinohrady, Prague
Registry updated 2026-06-23
NCT06875245
Comparing Efficacy of 8-Week and 12-Week Faricimab Initial Follow-Up Treatment Intervals
Trial Treatment · Phase 4 · Faculty Hospital Kralovske Vinohrady
Department of Ophthalmology, Faculty hospital Kralovske Vinohrady, Prague
Registry updated 2025-03-13

All Macular degeneration trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error